GPO to begin Phase 3 clinical trials of its COVID vaccine in December
Thailand’s Government Pharmaceutical Organisation (GPO) plans to begin Phase 3 clinical trials of its COVID-19 vaccine in December, after it obtains the findings of the Phase 2 tests, expected at